Budget Impact Analysis of An Etanercept Biosimilar for The Treatment of Rheumatoid Arthritis In Europe
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2276
https://www.valueinhealthjournal.com/article/S1098-3015(15)04352-1/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1690
First Page :
A639
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04352-1&doi=10.1016/j.jval.2015.09.2276